{
    "hands_on_practices": [
        {
            "introduction": "A core challenge in preventive medicine is the 'prevention paradox,' where a measure that brings large benefits to the community may offer little to each participating individual. A critical corollary to this is that even interventions with a very low per-person risk of harm can generate a substantial absolute number of adverse events when applied across a vast population. This first exercise  will guide you through a fundamental calculation to quantify this effect, known as iatrogenic harm, demonstrating why a population-wide strategy's potential for harm must be carefully weighed.",
            "id": "4556560",
            "problem": "A national preventive medicine program is considering two strategies for a prophylactic intervention known to have a small probability of causing harm. First, define iatrogenic harm as used in preventive medicine. Then, consider the following scientifically plausible scenario to reason from first principles about risk accumulation across a population: Each treated individual has an independent probability $p = 2.5 \\times 10^{-6}$ of experiencing a serious adverse reaction due solely to the intervention (that is, an iatrogenic harm). Under a population-based strategy, all eligible adults are offered the intervention, totaling $N_{\\mathrm{pop}} = 4.8 \\times 10^{7}$ individuals. Under a high-risk strategy, only those with a specified pre-existing condition are treated, totaling $N_{\\mathrm{high}} = 3.0 \\times 10^{6}$ individuals. Assume the probability $p$ is constant across individuals and independent between individuals. Using only fundamental definitions of probability and expectation, derive the expected total number of serious iatrogenic events for each strategy from first principles, and then compute the expected incremental number of serious iatrogenic events attributable to implementing the population-based strategy instead of the high-risk strategy. Express the final expected incremental number as a real number with no units and round to four significant figures.",
            "solution": "The problem statement is scientifically grounded, well-posed, objective, and complete. It presents a realistic scenario in preventive medicine and public health that can be rigorously analyzed using fundamental principles of probability theory. Therefore, the problem is deemed valid and a full solution is warranted.\n\nThe problem requires a definition of iatrogenic harm, a derivation of the expected number of adverse events from first principles, and a calculation of the incremental risk between two public health strategies.\n\nFirst, iatrogenic harm in preventive medicine refers to adverse health outcomes, injury, or complications that are caused by the preventive intervention itself, rather than by the disease or condition it is intended to prevent. The term originates from the Greek words *iatros* (healer) and *genesis* (origin). Examples include allergic reactions to vaccines, psychological distress from false-positive screening results, or, as in this problem, serious adverse reactions to a prophylactic medication.\n\nTo derive the expected total number of iatrogenic events from first principles, we model the outcome for each individual. Let $X_i$ be a random variable representing the outcome for the $i$-th individual who receives the intervention. We define $X_i = 1$ if the individual experiences a serious adverse reaction, and $X_i = 0$ otherwise. This is a Bernoulli trial.\n\nThe probability of an adverse reaction for any given individual is given as $p$. Therefore, the probability distribution for $X_i$ is:\n$P(X_i = 1) = p$\n$P(X_i = 0) = 1 - p$\n\nThe expected value of the random variable $X_i$ is, by definition for a discrete random variable:\n$$E[X_i] = \\sum_{x} x \\cdot P(X_i = x) = (1 \\cdot P(X_i = 1)) + (0 \\cdot P(X_i = 0))$$\n$$E[X_i] = (1 \\cdot p) + (0 \\cdot (1-p)) = p$$\n\nThe total number of iatrogenic events, $S_N$, in a population of size $N$ is the sum of the outcomes for all individuals in that population:\n$$S_N = \\sum_{i=1}^{N} X_i$$\nThe problem asks for the expected total number of events, which is the expected value of $S_N$. A fundamental property of expectation is its linearity, which states that the expectation of a sum of random variables is the sum of their individual expectations. This property holds regardless of whether the variables are independent.\n$$E[S_N] = E\\left[\\sum_{i=1}^{N} X_i\\right] = \\sum_{i=1}^{N} E[X_i]$$\nSince the probability $p$ is constant for all individuals, $E[X_i] = p$ for all $i$ from $1$ to $N$. Thus, the sum becomes:\n$$E[S_N] = \\sum_{i=1}^{N} p = N \\cdot p$$\nThis formula, derived from first principles, allows us to calculate the expected number of events for each strategy.\n\nFor the population-based strategy, the number of treated individuals is $N_{\\mathrm{pop}} = 4.8 \\times 10^7$, and the probability of an event per individual is $p = 2.5 \\times 10^{-6}$. The expected number of iatrogenic events, $E_{\\mathrm{pop}}$, is:\n$$E_{\\mathrm{pop}} = N_{\\mathrm{pop}} \\cdot p = (4.8 \\times 10^7) \\cdot (2.5 \\times 10^{-6})$$\n$$E_{\\mathrm{pop}} = (4.8 \\cdot 2.5) \\times 10^{7-6} = 12.0 \\times 10^1 = 120$$\n\nFor the high-risk strategy, the number of treated individuals is $N_{\\mathrm{high}} = 3.0 \\times 10^6$, with the same probability $p = 2.5 \\times 10^{-6}$. The expected number of iatrogenic events, $E_{\\mathrm{high}}$, is:\n$$E_{\\mathrm{high}} = N_{\\mathrm{high}} \\cdot p = (3.0 \\times 10^6) \\cdot (2.5 \\times 10^{-6})$$\n$$E_{\\mathrm{high}} = (3.0 \\cdot 2.5) \\times 10^{6-6} = 7.5 \\times 10^0 = 7.5$$\n\nThe expected incremental number of serious iatrogenic events, $\\Delta E$, attributable to implementing the population-based strategy instead of the high-risk strategy is the difference between their respective expected values:\n$$\\Delta E = E_{\\mathrm{pop}} - E_{\\mathrm{high}}$$\n$$\\Delta E = 120 - 7.5 = 112.5$$\nAlternatively, this can be calculated as:\n$$\\Delta E = (N_{\\mathrm{pop}} - N_{\\mathrm{high}}) \\cdot p = (4.8 \\times 10^7 - 3.0 \\times 10^6) \\cdot (2.5 \\times 10^{-6})$$\n$$\\Delta E = (48.0 \\times 10^6 - 3.0 \\times 10^6) \\cdot (2.5 \\times 10^{-6})$$\n$$\\Delta E = (45.0 \\times 10^6) \\cdot (2.5 \\times 10^{-6})$$\n$$\\Delta E = (45.0 \\cdot 2.5) \\times 10^{6-6} = 112.5$$\n\nThe problem requires the final answer to be rounded to four significant figures. The calculated value $112.5$ has exactly four significant figures ($1$, $1$, $2$, $5$), so no further rounding is necessary.",
            "answer": "$$\\boxed{112.5}$$"
        },
        {
            "introduction": "While high-risk strategies are efficient in theory, their real-world success depends critically on our ability to accurately identify the target group. In practice, we rely on screening tests that are never perfect. This next practice problem  explores how a test's sensitivity and specificity determine the ultimate balance of benefits and harms, forcing us to account for the consequences of both true and false test results. By calculating the net effect, you will gain a deeper appreciation for the trade-offs inherent in any screening-based intervention.",
            "id": "4556632",
            "problem": "A public health department is evaluating two strategies for preventing a specific cardiovascular event in an adult population. The disease occurs at different baseline annual incidences among truly high-risk and truly low-risk individuals, and a risk classification test is available to target a more intensive intervention to those deemed at high risk.\n\nFundamental definitions and facts to be used:\n- Sensitivity is the probability that the test is positive given that an individual is truly high risk.\n- Specificity is the probability that the test is negative given that an individual is truly low risk.\n- Incidence is the probability of the event occurring within a specified time period in a defined group.\n- An intervention that reduces risk by a proportion $r$ changes an individual’s incidence from $I$ to $(1-r)I$, yielding an expected prevented number of events equal to $r \\times I$ per person treated over the period considered.\n- A harm rate $h$ for an intervention is the probability of a serious adverse event per person treated over the period considered, independent of disease risk status.\n- Expected counts are computed by multiplying probabilities by population counts under the assumption of independent risks.\n\nScenario:\n- Population size is $N = 100000$ adults.\n- The prevalence of truly high-risk status is $\\pi = 0.15$, so truly low-risk prevalence is $1 - \\pi$.\n- Annual disease incidence among truly high-risk individuals is $I_{H} = 0.02$.\n- Annual disease incidence among truly low-risk individuals is $I_{L} = 0.002$.\n- The risk classification test has sensitivity $\\text{Se} = 0.80$ and specificity $\\text{Sp} = 0.90$.\n- Targeted intensive intervention is offered only to those who test positive. It reduces incidence by a proportion $r = 0.50$ for truly high-risk individuals and provides no meaningful benefit for truly low-risk individuals. It has a serious harm rate $h = 0.001$ per person treated.\n- The universal population-based low-intensity policy is offered to everyone. It reduces incidence by a proportion $b = 0.05$ uniformly for all individuals and has negligible serious harm, $s = 0$ per person.\n\nTask:\n1. Using only the definitions above, derive an expression for the expected net number of disease events prevented minus serious harms caused in one year under the targeted strategy, expressed in terms of $N$, $\\pi$, $I_{H}$, $I_{L}$, $\\text{Se}$, $\\text{Sp}$, $r$, and $h$.\n2. Derive an expression for the expected net number of disease events prevented minus serious harms caused in one year under the universal policy, expressed in terms of $N$, $\\pi$, $I_{H}$, $I_{L}$, $b$, and $s$.\n3. Compute the numerical value of the targeted strategy’s net effect minus the universal policy’s net effect (i.e., the net advantage of targeted over universal), for one year in this population.\n\nExpress your final answer as the expected net number of events per $100000$ persons per year. Round your final answer to three significant figures.",
            "solution": "The problem statement has been validated and is deemed scientifically grounded, well-posed, and objective. It presents a standard scenario in quantitative public health policy analysis. We can proceed with the solution.\n\nThe solution is partitioned into three parts, corresponding to the three tasks requested in the problem statement.\n\n### Part 1: Net Effect of the Targeted Strategy\n\nThe targeted strategy involves applying an intensive intervention only to individuals who test positive on a risk classification test. The net effect is the number of disease events prevented minus the number of serious harms caused.\n\nLet $H$ denote the event that an individual is truly high-risk and $L$ the event that they are truly low-risk. Let $T+$ denote a positive test result. The probabilities of these states are given as $P(H) = \\pi$ and $P(L) = 1 - \\pi$.\nThe test's characteristics are given by its sensitivity, $\\text{Se} = P(T+\\,|\\,H)$, and specificity, $\\text{Sp} = P(T-\\,|\\,L)$, where $T-$ is a negative test result. This implies $P(T+\\,|\\,L) = 1 - \\text{Sp}$.\n\nFirst, we determine the number of individuals who are treated. The intervention is given to all who test positive. The number of individuals testing positive is the sum of true positives (high-risk individuals testing positive) and false positives (low-risk individuals testing positive).\n- Number of truly high-risk individuals: $N \\pi$.\n- Number of truly low-risk individuals: $N(1-\\pi)$.\n- Number of true positives ($N_{TP}$): High-risk individuals who test positive. $N_{TP} = (N\\pi) \\times \\text{Se}$.\n- Number of false positives ($N_{FP}$): Low-risk individuals who test positive. $N_{FP} = N(1-\\pi) \\times (1-\\text{Sp})$.\n\nThe total number of individuals treated under the targeted strategy, $N_{\\text{treated}}$, is:\n$$N_{\\text{treated}} = N_{TP} + N_{FP} = N\\pi\\text{Se} + N(1-\\pi)(1-\\text{Sp}) = N[\\pi\\text{Se} + (1-\\pi)(1-\\text{Sp})]$$\n\nNext, we calculate the expected number of events prevented. The intervention reduces incidence by a proportion $r$ for truly high-risk individuals and has no benefit for low-risk individuals. Therefore, events are only prevented among the true positives.\nThe expected number of events prevented, $E_{\\text{prevented, targeted}}$, is:\n$$E_{\\text{prevented, targeted}} = N_{TP} \\times I_H \\times r = (N\\pi\\text{Se})I_H r$$\n\nNext, we calculate the expected number of serious harms caused. Harms occur at a rate $h$ for every person treated, regardless of risk status.\nThe expected number of harms, $H_{\\text{harms, targeted}}$, is:\n$$H_{\\text{harms, targeted}} = N_{\\text{treated}} \\times h = N[\\pi\\text{Se} + (1-\\pi)(1-\\text{Sp})]h$$\n\nThe net effect of the targeted strategy, $E_{\\text{net, targeted}}$, is the difference between events prevented and harms caused.\n$$E_{\\text{net, targeted}} = E_{\\text{prevented, targeted}} - H_{\\text{harms, targeted}}$$\n$$E_{\\text{net, targeted}} = N\\pi\\text{Se}rI_H - N[\\pi\\text{Se} + (1-\\pi)(1-\\text{Sp})]h$$\nFactoring out $N$, the expression for the expected net number of events is:\n$$E_{\\text{net, targeted}} = N\\left( \\pi\\text{Se}rI_H - \\left[\\pi\\text{Se} + (1-\\pi)(1-\\text{Sp})\\right]h \\right)$$\n\n### Part 2: Net Effect of the Universal Policy\n\nThe universal policy involves applying a low-intensity intervention to the entire population of size $N$. This intervention reduces incidence by a uniform proportion $b$ for all individuals and has a harm rate of $s$.\n\nFirst, we calculate the expected number of events prevented. The benefit applies to both high-risk and low-risk individuals.\n- Events prevented in the high-risk group: $(N\\pi) \\times I_H \\times b$.\n- Events prevented in the low-risk group: $N(1-\\pi) \\times I_L \\times b$.\n\nThe total expected number of events prevented, $E_{\\text{prevented, universal}}$, is the sum of these:\n$$E_{\\text{prevented, universal}} = N\\pi b I_H + N(1-\\pi)b I_L = Nb[\\pi I_H + (1-\\pi)I_L]$$\nThe term $\\pi I_H + (1-\\pi)I_L$ represents the average baseline incidence in the population.\n\nNext, we calculate the expected number of serious harms. The harm rate $s$ applies to the entire population $N$.\nThe expected number of harms, $H_{\\text{harms, universal}}$, is:\n$$H_{\\text{harms, universal}} = Ns$$\n\nThe net effect of the universal policy, $E_{\\text{net, universal}}$, is:\n$$E_{\\text{net, universal}} = E_{\\text{prevented, universal}} - H_{\\text{harms, universal}}$$\n$$E_{\\text{net, universal}} = Nb[\\pi I_H + (1-\\pi)I_L] - Ns$$\nFactoring out $N$, the expression is:\n$$E_{\\text{net, universal}} = N\\left( b[\\pi I_H + (1-\\pi)I_L] - s \\right)$$\n\n### Part 3: Numerical Calculation of the Net Advantage\n\nThe net advantage of the targeted strategy over the universal policy is the difference in their net effects, $\\Delta E = E_{\\text{net, targeted}} - E_{\\text{net, universal}}$.\n\nFirst, we compute the numerical value for $E_{\\text{net, targeted}}$ using the given parameters:\n$N = 100000$, $\\pi = 0.15$, $I_H = 0.02$, $I_L = 0.002$, $\\text{Se} = 0.80$, $\\text{Sp} = 0.90$, $r = 0.50$, $h = 0.001$.\n\nEvents prevented (Targeted):\n$$E_{\\text{prevented, targeted}} = 100000 \\times 0.15 \\times 0.80 \\times 0.50 \\times 0.02 = 100000 \\times 0.0012 = 120$$\nHarms caused (Targeted):\nThe proportion of the population treated is $\\pi\\text{Se} + (1-\\pi)(1-\\text{Sp}) = (0.15)(0.80) + (1-0.15)(1-0.90) = 0.12 + (0.85)(0.10) = 0.12 + 0.085 = 0.205$.\nTotal people treated is $100000 \\times 0.205 = 20500$.\n$$H_{\\text{harms, targeted}} = 20500 \\times 0.001 = 20.5$$\nNet effect (Targeted):\n$$E_{\\text{net, targeted}} = 120 - 20.5 = 99.5$$\n\nNext, we compute the numerical value for $E_{\\text{net, universal}}$:\n$N = 100000$, $\\pi = 0.15$, $I_H = 0.02$, $I_L = 0.002$, $b = 0.05$, $s = 0$.\n\nEvents prevented (Universal):\nThe average baseline incidence is $\\pi I_H + (1-\\pi)I_L = (0.15)(0.02) + (0.85)(0.002) = 0.003 + 0.0017 = 0.0047$.\n$$E_{\\text{prevented, universal}} = 100000 \\times 0.05 \\times 0.0047 = 100000 \\times 0.000235 = 23.5$$\nHarms caused (Universal):\n$$H_{\\text{harms, universal}} = 100000 \\times 0 = 0$$\nNet effect (Universal):\n$$E_{\\text{net, universal}} = 23.5 - 0 = 23.5$$\n\nFinally, we compute the net advantage of the targeted strategy:\n$$\\Delta E = E_{\\text{net, targeted}} - E_{\\text{net, universal}} = 99.5 - 23.5 = 76$$\nThe problem asks for the answer to be rounded to three significant figures. The exact value $76$ is expressed as $76.0$ to meet this requirement.\nThe net advantage of the targeted strategy over the universal policy is an expected $76.0$ net events prevented per $100000$ persons per year.",
            "answer": "$$\\boxed{76.0}$$"
        },
        {
            "introduction": "Preventive medicine is often a science of resource allocation, where the goal is to achieve the greatest health gain from a limited budget. Rather than making an all-or-nothing choice between a population and a high-risk strategy, the optimal approach often involves a carefully balanced portfolio of both. This advanced exercise  introduces the formal method of constrained optimization to solve this very problem, demonstrating how to allocate funds to maximize benefits in the face of diminishing returns. Mastering this approach provides a powerful tool for rational public health planning.",
            "id": "4556567",
            "problem": "A public health department seeks to allocate a fixed budget across two prevention strategies to maximize expected health gains, measured in Disability-Adjusted Life Years (DALYs) averted. The first is a population-wide policy with diminishing returns from scale, and the second is a targeted high-risk program with decreasing marginal benefits as coverage grows. Let the allocation to the population policy be $x$ and to the high-risk program be $y$, both measured in millions of dollars. The total budget is $B = 10$ million dollars, so $x + y \\leq 10$, with $x \\geq 0$ and $y \\geq 0$.\n\nThe expected DALYs averted from the population policy are modeled by a concave benefit function $f(x) = \\alpha \\ln(1 + \\beta x)$ with $\\alpha = 1$ and $\\beta = 1$, and the expected DALYs averted from the high-risk program are modeled by a concave benefit function $g(y) = \\gamma \\sqrt{y}$ with $\\gamma = 2$. The total benefit to be maximized is $f(x) + g(y)$.\n\nStarting from core definitions of concavity and the Karush-Kuhn-Tucker (KKT) optimality framework, and without using any shortcut formulas, formulate the constrained optimization problem exactly, derive the KKT conditions, and solve them to obtain the optimal allocation $(x^{*}, y^{*})$. Express the allocations in millions of dollars. Provide $x^{*}$ and $y^{*}$ exactly (do not round).",
            "solution": "The problem is a constrained optimization problem that seeks to maximize a utility function subject to budget and non-negativity constraints. The problem is valid as it is scientifically grounded in economic and optimization theory, well-posed, and all necessary data are provided. The objective function is concave and the feasible region is a compact convex set, which guarantees that a global maximum exists and that the Karush-Kuhn-Tucker (KKT) conditions are sufficient for optimality.\n\nFirst, we formally state the optimization problem.\nLet $x$ be the allocation to the population policy and $y$ be the allocation to the high-risk program, both in millions of dollars.\nThe objective is to maximize the total benefit function $U(x, y)$, given by:\n$$ U(x, y) = f(x) + g(y) = \\ln(1 + x) + 2\\sqrt{y} $$\nThe constraints on the allocations are:\n1. Budget constraint: $x + y \\leq 10$\n2. Non-negativity constraints: $x \\geq 0$, $y \\geq 0$\n\nThe problem is to maximize a continuously differentiable, concave objective function over a non-empty, compact, and convex feasible region. The concavity of the objective function is established by examining the second derivatives of its components. For $f(x) = \\ln(1+x)$, the second derivative is $f''(x) = -\\frac{1}{(1+x)^2}$, which is negative for $x \\geq 0$. For $g(y) = 2\\sqrt{y}$, the second derivative is $g''(y) = -\\frac{1}{2}y^{-3/2}$, which is negative for $y > 0$. The sum of two concave functions is concave, so $U(x,y)$ is concave. The feasible region defined by the linear inequalities is a convex set. Therefore, any point $(x^*, y^*)$ that satisfies the KKT conditions will be a global maximum.\n\nTo apply the KKT framework, we rewrite the constraints in the standard form $h_i(x,y) \\leq 0$:\n$h_1(x, y) = x + y - 10 \\leq 0$\n$h_2(x, y) = -x \\leq 0$\n$h_3(x, y) = -y \\leq 0$\n\nThe Lagrangian function $\\mathcal{L}$ is constructed by incorporating the objective function and the constraints with their respective Lagrange multipliers ($\\lambda_1, \\lambda_2, \\lambda_3$):\n$$ \\mathcal{L}(x, y, \\lambda_1, \\lambda_2, \\lambda_3) = U(x, y) - \\lambda_1 h_1(x, y) - \\lambda_2 h_2(x, y) - \\lambda_3 h_3(x, y) $$\n$$ \\mathcal{L}(x, y, \\lambda_1, \\lambda_2, \\lambda_3) = \\ln(1 + x) + 2\\sqrt{y} - \\lambda_1(x + y - 10) - \\lambda_2(-x) - \\lambda_3(-y) $$\n$$ \\mathcal{L}(x, y, \\lambda_1, \\lambda_2, \\lambda_3) = \\ln(1 + x) + 2\\sqrt{y} - \\lambda_1(x + y - 10) + \\lambda_2 x + \\lambda_3 y $$\n\nThe KKT conditions for optimality are as follows:\n\n1.  **Stationarity:** The partial derivatives of the Lagrangian with respect to the decision variables must be zero.\n    $$ \\frac{\\partial \\mathcal{L}}{\\partial x} = \\frac{1}{1 + x} - \\lambda_1 + \\lambda_2 = 0 \\quad (1) $$\n    $$ \\frac{\\partial \\mathcal{L}}{\\partial y} = \\frac{2}{2\\sqrt{y}} - \\lambda_1 + \\lambda_3 = \\frac{1}{\\sqrt{y}} - \\lambda_1 + \\lambda_3 = 0 \\quad (2) $$\n    Note that equation $(2)$ requires $y > 0$. We will proceed by assuming an interior solution ($x > 0, y > 0$) and verify this assumption later.\n\n2.  **Primal Feasibility:** The constraints must be satisfied.\n    $$ x + y - 10 \\leq 0 \\quad (3) $$\n    $$ x \\geq 0, \\quad y \\geq 0 \\quad (4) $$\n\n3.  **Dual Feasibility:** The Lagrange multipliers for inequality constraints must be non-negative.\n    $$ \\lambda_1 \\geq 0, \\quad \\lambda_2 \\geq 0, \\quad \\lambda_3 \\geq 0 \\quad (5) $$\n\n4.  **Complementary Slackness:** The product of each Lagrange multiplier and its corresponding constraint slack must be zero.\n    $$ \\lambda_1 (x + y - 10) = 0 \\quad (6) $$\n    $$ \\lambda_2 x = 0 \\quad (7) $$\n    $$ \\lambda_3 y = 0 \\quad (8) $$\n\nWe now solve this system of equations and inequalities. The marginal benefit from allocating to $y$, given by $g'(y) = 1/\\sqrt{y}$, approaches infinity as $y$ approaches $0$. This suggests that it will always be optimal to allocate some positive amount to the high-risk program, so we can assume $y^* > 0$. From the complementary slackness condition $(8)$, if $y > 0$, then $\\lambda_3 = 0$.\n\nSimilarly, the marginal benefit from allocating to $x$, given by $f'(x) = 1/(1+x)$, is $1$ at $x=0$, which is positive and significant. This suggests it is also optimal to allocate a positive amount to the population policy, so we assume $x^* > 0$. From the complementary slackness condition $(7)$, if $x > 0$, then $\\lambda_2 = 0$.\n\nWith $\\lambda_2 = 0$ and $\\lambda_3 = 0$, the stationarity conditions $(1)$ and $(2)$ simplify to:\n$$ \\frac{1}{1 + x} - \\lambda_1 = 0 \\implies \\lambda_1 = \\frac{1}{1 + x} \\quad (9) $$\n$$ \\frac{1}{\\sqrt{y}} - \\lambda_1 = 0 \\implies \\lambda_1 = \\frac{1}{\\sqrt{y}} \\quad (10) $$\nSince $x > 0$ and $y > 0$, both expressions for $\\lambda_1$ are positive. Thus, $\\lambda_1 > 0$. From the complementary slackness condition $(6)$, if $\\lambda_1 > 0$, then the budget constraint must be active:\n$$ x + y - 10 = 0 \\implies y = 10 - x \\quad (11) $$\nNow we equate the two expressions for $\\lambda_1$ from $(9)$ and $(10)$:\n$$ \\frac{1}{1 + x} = \\frac{1}{\\sqrt{y}} \\implies \\sqrt{y} = 1 + x $$\nSubstitute the expression for $y$ from $(11)$ into this equation:\n$$ \\sqrt{10 - x} = 1 + x $$\nTo solve for $x$, we square both sides. We must ensure $x$ is in a range where this is valid. Since $x \\geq 0$, $1+x > 0$. The term $\\sqrt{10-x}$ requires $10-x \\geq 0$, or $x \\leq 10$. Both conditions are consistent with the problem's constraints.\n$$ 10 - x = (1 + x)^2 $$\n$$ 10 - x = 1 + 2x + x^2 $$\nRearranging gives a quadratic equation in $x$:\n$$ x^2 + 3x - 9 = 0 $$\nWe solve for $x$ using the quadratic formula, $x = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a}$:\n$$ x = \\frac{-3 \\pm \\sqrt{3^2 - 4(1)(-9)}}{2(1)} = \\frac{-3 \\pm \\sqrt{9 + 36}}{2} = \\frac{-3 \\pm \\sqrt{45}}{2} $$\nSimplifying the square root, $\\sqrt{45} = \\sqrt{9 \\times 5} = 3\\sqrt{5}$.\n$$ x = \\frac{-3 \\pm 3\\sqrt{5}}{2} $$\nSince $x$ must be non-negative ($x \\geq 0$), we take the positive root:\n$$ x^* = \\frac{-3 + 3\\sqrt{5}}{2} $$\nWe verify that this solution is positive. Since $\\sqrt{5} > \\sqrt{1} = 1$, $3\\sqrt{5} > 3$, so $-3 + 3\\sqrt{5} > 0$. The solution is valid.\n\nNow we find the optimal allocation $y^*$ using equation $(11)$:\n$$ y^* = 10 - x^* = 10 - \\left(\\frac{-3 + 3\\sqrt{5}}{2}\\right) = \\frac{20 - (-3 + 3\\sqrt{5})}{2} = \\frac{20 + 3 - 3\\sqrt{5}}{2} $$\n$$ y^* = \\frac{23 - 3\\sqrt{5}}{2} $$\nWe verify this solution is positive. $23^2 = 529$ and $(3\\sqrt{5})^2 = 9 \\times 5 = 45$. Since $529 > 45$, we have $23 > 3\\sqrt{5}$, and thus $y^* > 0$.\n\nOur initial assumptions that $x^* > 0$ and $y^* > 0$ are consistent with the calculated solution. Thus, the optimal allocation is:\n$x^* = \\frac{-3 + 3\\sqrt{5}}{2}$\n$y^* = \\frac{23 - 3\\sqrt{5}}{2}$\nThese values satisfy all KKT conditions, and due to the concave nature of the problem, this solution represents the global maximum for the expected DALYs averted.",
            "answer": "$$ \\boxed{ \\begin{pmatrix} \\frac{-3 + 3\\sqrt{5}}{2} & \\frac{23 - 3\\sqrt{5}}{2} \\end{pmatrix} } $$"
        }
    ]
}